JP2013543581A5 - - Google Patents

Download PDF

Info

Publication number
JP2013543581A5
JP2013543581A5 JP2013529664A JP2013529664A JP2013543581A5 JP 2013543581 A5 JP2013543581 A5 JP 2013543581A5 JP 2013529664 A JP2013529664 A JP 2013529664A JP 2013529664 A JP2013529664 A JP 2013529664A JP 2013543581 A5 JP2013543581 A5 JP 2013543581A5
Authority
JP
Japan
Prior art keywords
individual
hbp
determining whether
concentration
bacterial meningitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013529664A
Other languages
English (en)
Japanese (ja)
Other versions
JP5891230B2 (ja
JP2013543581A (ja
Filing date
Publication date
Priority claimed from GBGB1016161.0A external-priority patent/GB201016161D0/en
Application filed filed Critical
Publication of JP2013543581A publication Critical patent/JP2013543581A/ja
Publication of JP2013543581A5 publication Critical patent/JP2013543581A5/ja
Application granted granted Critical
Publication of JP5891230B2 publication Critical patent/JP5891230B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013529664A 2010-09-24 2011-09-23 細菌性髄膜炎の治療方法 Active JP5891230B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1016161.0 2010-09-24
GBGB1016161.0A GB201016161D0 (en) 2010-09-24 2010-09-24 Diagnostic method
PCT/EP2011/066611 WO2012038541A1 (en) 2010-09-24 2011-09-23 Diagnostic method for bacterial meningitis

Publications (3)

Publication Number Publication Date
JP2013543581A JP2013543581A (ja) 2013-12-05
JP2013543581A5 true JP2013543581A5 (enExample) 2014-10-02
JP5891230B2 JP5891230B2 (ja) 2016-03-22

Family

ID=43127976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013529664A Active JP5891230B2 (ja) 2010-09-24 2011-09-23 細菌性髄膜炎の治療方法

Country Status (6)

Country Link
US (1) US9759720B2 (enExample)
EP (1) EP2619583B1 (enExample)
JP (1) JP5891230B2 (enExample)
CN (1) CN103250054B (enExample)
GB (1) GB201016161D0 (enExample)
WO (1) WO2012038541A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
GB201518597D0 (en) * 2015-10-20 2015-12-02 Univ Liverpool Detection of bacterial infection
US11287396B2 (en) 2020-06-05 2022-03-29 Princeton Biochemicals, Inc. Method and system for simultaneous determination of multiple measurable biomarkers during the development of a communicable disease
CN111951963B (zh) 2020-07-30 2022-09-02 中翰盛泰生物技术股份有限公司 Hbp在covid-19患者的预后风险预警中的应用
CN111951969A (zh) * 2020-08-05 2020-11-17 中翰盛泰生物技术股份有限公司 Hbp在高危妊娠预测中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627262A (en) 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5962241A (en) 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
US5314804A (en) 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
NZ332683A (en) * 1994-04-21 2001-06-29 Novo Nordisk As Use of heparin binding protein to prevent or treat sepsis
US5976536A (en) * 1995-08-09 1999-11-02 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
US5778895A (en) 1997-01-29 1998-07-14 Uab Research Foundation Method of discriminating bacterial from aseptic meningitis
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US20030170745A1 (en) 2002-03-08 2003-09-11 Pereira Heloise Anne Early detection marker for chronic inflammatory associated diseases
US7655480B2 (en) 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
EP1581556A2 (en) * 2002-08-15 2005-10-05 Leukotech A/S Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp)
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
WO2004112713A2 (en) 2003-06-20 2004-12-29 Royer Biomedical, Inc. Drug polymer complexes
WO2005028512A1 (en) 2003-09-19 2005-03-31 Leukotech A/S Pro-inflammatory and anti-inflammatory antibodies against the heparin-binding protein (hbp)
US20050196817A1 (en) 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
BRPI0609302A2 (pt) 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
CA2624569A1 (en) 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
GB0521276D0 (en) 2005-10-19 2005-11-30 Lewitt Moira S Medical uses and therapies based upon the action of azurocidin on IGFBP-1
FR2894675B1 (fr) * 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) * 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method

Similar Documents

Publication Publication Date Title
JP2013543581A5 (enExample)
JP2014521089A5 (enExample)
WO2012142301A3 (en) Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
WO2010082944A3 (en) Systems and methods for imaging changes in tissue
WO2015014903A3 (en) Diagnostic tools for alzheimer's disease
JP2016118568A5 (enExample)
WO2006073682A3 (en) Diagnostic test
RU2014105172A (ru) Способ обнаружения олигомеров бета-амилоида в образце жидкости организма и варианты его применения
WO2011156734A3 (en) Method of characterizing vascular diseases
WO2009001545A1 (ja) 移植片対宿主疾患の検査および治療方法
WO2007136617A3 (en) Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury
Bloos Clinical diagnosis of sepsis and the combined use of biomarkers and culture-and non-culture-based assays
JP2014523525A5 (enExample)
EA201291040A1 (ru) Использование скорости увеличения желудочков при лечении болезни альцгеймера внутривенным иммуноглобулином
WO2011112670A3 (en) Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
EP2152303A4 (en) CHLAMYDIA ANTIGENS AS REAGENTS FOR THE DIAGNOSIS AND TREATMENT OF CHLAMYDIA INFECTION AND DISEASE
WO2010121834A3 (en) Irak kinase family as novel target and biomarker for alzheimer
Kováč et al. Milk amyloid A and selected serum proteins in cows suffering from mastitis
BR112013030646A2 (pt) uso diagnóstico de pró-somatostatina
WO2014197460A8 (en) Methods for diagnosing and treating bicuspid aortic valve and/or aortopathies
WO2007042827A3 (en) Treatment and diagnosis of obligate intracellular pathogens
Hsu et al. Prognostic factors for patients with culture-positive Candida infection undergoing abdominal surgery
WO2013006034A3 (en) A diagnostic kit for the detection of early acute leptospirosis
US20170227534A1 (en) Urinary crystal detection method
EP2371376A4 (en) METHOD AND REAGENTS FOR DIAGNOSIS, PREVENTION AND TREATMENT OF INSULIN RESISTANCE